Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaochen Li

Showing results (261-270 of 281) with videos related to

Pageof 29
Sort By:
JCO Precision Oncology|May 18, 2026
Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing <i>ALK</i> Alteration Prolongs Treatment DurationVitor Abreu de Góes, Matthew Lee, Miguel Zugman, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
BJU International|July 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinomaAbhishek Tripathi, Catherine M Tangen, Melissa Plets, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
Cell Reports. Medicine|June 16, 2026
The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided careAritro Nath, Jyoti Malhotra, Isa Mambetsariev, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
Nutrients|June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic TherapyHedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Clinical & Translational Immunology|February 22, 2021
High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responsesMin Xie, Joseph Yunis, Yin Yao, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
Cancers|October 16, 2025
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder CancerSalvador Jaime-Casas, Wesley Yip, Daniel J Lama, et al.
Pageof 29

Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
JCO Precision Oncology|May 18, 2026
Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing <i>ALK</i> Alteration Prolongs Treatment DurationVitor Abreu de Góes, Matthew Lee, Miguel Zugman, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
BJU International|July 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinomaAbhishek Tripathi, Catherine M Tangen, Melissa Plets, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
Cell Reports. Medicine|June 16, 2026
The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided careAritro Nath, Jyoti Malhotra, Isa Mambetsariev, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
Nutrients|June 19, 2024
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic TherapyHedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, et al.
Clinical & Translational Immunology|February 22, 2021
High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responsesMin Xie, Joseph Yunis, Yin Yao, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
Cancers|October 16, 2025
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder CancerSalvador Jaime-Casas, Wesley Yip, Daniel J Lama, et al.
Pageof 29